Form 4: IBM Director Defers Fees into 377 Shares
Insider Transaction Report
IBM Director Thomas Buberl deferred fees into 377 Promised Fee Shares under the company's deferred compensation plan.
Summary
- Thomas Buberl, a Director at International Business Machines Corp (IBM), deferred fees into 377 Promised Fee Shares.
- The transaction occurred on March 31, 2026, as part of the IBM Board of Directors Deferred Compensation and Equity Award Plan.
- The underlying common stock for the acquired shares was valued at $242.39 per share.
- Following this transaction, Buberl beneficially owns 14,278 derivative securities.
- Distribution of these shares is deferred until retirement and will be paid out in common stock or cash.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a routine, slightly positive event, as it demonstrates a director's continued alignment with shareholder interests through deferred equity compensation.
Positives
- Director Thomas Buberl is increasing his deferred equity holdings in IBM, aligning his interests with shareholders.
- The deferral mechanism indicates a long-term commitment to the company.
Risks
- The value of the deferred shares is subject to the future performance of IBM's common stock until distribution at retirement.
Future Outlook
The Promised Fee Shares will be paid out after retirement in the company's common stock or cash, indicating a long-term compensation structure tied to future company performance.
Management Comments
- Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.
- Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.
- Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
Industry Context
StockSavvy.ai notes that deferred compensation plans, particularly for board members, are a common practice across large-cap technology and enterprise companies. These plans aim to align the long-term interests of directors with those of shareholders by tying a portion of their compensation to the company's stock performance over an extended period.
Comparison to Industry Standards
- Many S&P 500 companies, including peers like Microsoft and Oracle, utilize similar deferred compensation plans for their non-employee directors, often involving equity awards or phantom stock units that vest or are distributed upon retirement or departure from the board.
- The structure of deferring fees into equity-linked instruments is a standard corporate governance practice designed to foster long-term commitment and mitigate short-term decision-making.
Stakeholder Impact
- Shareholders: Increased alignment of a director's long-term interests with shareholder value through equity-based compensation.
- Employees: No direct impact mentioned.
Next Steps
- Distribution of the Promised Fee Shares to Thomas Buberl upon his retirement from the IBM Board of Directors.
Key Dates
| Date | Description |
|---|---|
| 03/31/2026 | Transaction date for the deferral of fees into Promised Fee Shares. |
| 04/01/2026 | Date the Form 4 was signed and filed. |
Recommendation
holdThis Form 4 filing reports a routine deferral of director fees into equity, which is a standard compensation practice and does not provide new material information to warrant a change in investment recommendation. It indicates continued director alignment but does not reflect new operational performance or strategic shifts.
Keywords
IBM, Thomas Buberl, Director, Deferred Compensation, Equity Award Plan, Form 4, Insider Transaction, Stock Deferral
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.